"Anti-healing" versus "pro-healing"

Catheterization and Cardiovascular Interventions

Volumn 71, Issue 5, 2008, Pages 605-606

  Seth, Ashok ^a,b  

^a Max Heart and Vascular Institute   (India)

^b NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; PACLITAXEL; RAPAMYCIN;

ANTICOAGULATION; BLOOD VESSEL INJURY; DRUG ELUTING STENT; HEALING; HEART INFARCTION; NOTE; RESTENOSIS; THROMBOSIS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES; ANTIGENS, CD34; COATED MATERIALS, BIOCOMPATIBLE; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG-ELUTING STENTS; ENDOTHELIAL CELLS; HOSPITAL MORTALITY; HUMANS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROSTHESIS DESIGN; REGISTRIES; STAINLESS STEEL; STEM CELLS; STENTS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; WOUND HEALING;

EID: 42249107677     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21571     Document Type: Note

References (3)

1. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in man: Delayed healing and late thrombosis risk. J Am Coll Cardiol 2006;48:193-202.
2. Inoue T, Sata M, Hikichi Y, Sohma R, Fukuda D, Uchida T, Shimizu M, Komoda H, Node K. Mobilization of CD34 - Positive bone marrow - Derived cells after coronary stent implantation: Impact on restenosis. Circulation 2007;115:553-561.
3. Lüscher TF, Steffel J, Eberli FR. Joner M, Nakazawa G, Tanner FC, Virmani R. Drug eluting stent and coronary thrombosis: Biological mechanisms and clinical implications. Circulation 2007;115:1051-1058.